Open Access This book is distributed under the terms of the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Contents
- Preface
- I. Basic Research for Innovative Medicine
- Diverting Glycolysis to Combat Oxidative StressEdouard Mullarky and Lewis C. Cantley.
- Metabolic Regulation by Nuclear ReceptorsSihao Liu, Michael Downes, and Ronald M. Evans.
- Fighting Fire with Fire in CancerThorsten Berger, Mary E. Saunders, and Tak W. Mak.
- Linear Polyubiquitination: A Crucial Regulator of NF-κB ActivationKazuhiro Iwai.
- VCP, a Major ATPase in the Cells, as a Novel Drug Target for Currently Incurable DisordersAkira Kakizuka.
- Background
- VCP in Neurodegenerative Disorders
- Development of Novel Inhibitors (KUSs) of VCP ATPase Activity That Do Not Block VCP Cellular Functions
- KUSs Protected Cells Under ER Stress-Inducing Conditions
- KUSs or Exogenous ATP Prevented ER Stress in Cultured Cells
- KUSs Mitigated Pathologies of rd10, a Mouse Model of Retinitis Pigmentosa
- Discussion
- References
- Roles of E-cadherin in HepatocarcinogenesisShin Maeda and Hayato Nakagawa.
- The Hippo Signaling Pathway: A Candidate New Drug Target for Malignant TumorsMiki Nishio, Hiroki Goto, Miki Suzuki, Aya Fujimoto, Koshi Mimori, and Akira Suzuki.
- Introduction
- Loss of Hippo Signaling in the Liver
- Loss of Hippo Signaling in the Pancreas
- Loss of Hippo Signaling in the Intestine
- Loss of Hippo Signaling in the Lung
- Loss of Hippo Signaling in the Skin
- Loss of Hippo Signaling in T Lymphocytes
- Loss of Hippo Signaling in Salivary Glands
- Loss of Hippo Signaling in Neurons
- Loss of Hippo Signaling in Bone
- Concluding Remarks
- Acknowledgments
- References
- Inhibitory Immunoreceptors on Mast Cells in Allergy and InflammationAkira Shibuya, Chigusa Nakahashi-Oda, and Satoko Tahara-Hanaoka.
- Doxycycline-Inducible Autoimmune Blistering Skin Disease ModelWataru Nishie and Hiroshi Shimizu.
- T Cell Senescence and AutoimmunityNagahiro Minato, Professor.
- Introduction: Immune Aging and Senescence-Associated T Cells
- SA-T Cells Represent an Endogenously Arising Follicular T Cell Population with Age
- SA-T Cells Increase Robustly in Bone Fide Lupus-Prone Mice
- SA-T Cells Show Typical Signs and Features of Cellular Senescence
- SA-T Cells Are Activated in Response to Autologous GC B Cells to Produce OPN that Protects Against B Cell Apoptosis in GCs
- Involvement of SA-T Cells in the Expansion of GCs and Autoimmunity in Lupus
- Conclusion and Perspectives
- References
- Diverting Glycolysis to Combat Oxidative Stress
- II. Translational Research for Innovative Medicine
- IL-6: A New Era for the Treatment of Autoimmune Inflammatory DiseasesTadamitsu Kishimoto, Sujin Kang, and Toshio Tanaka.
- Introduction
- Pleiotropic Function of IL-6
- IL-6 Signaling Systems
- Regulatory Mechanisms of IL-6 Synthesis
- Pathological Role of IL-6 in Autoimmune Inflammatory Diseases
- IL-6-Targeting Strategies: A New Era for the Treatment of Autoimmune Inflammatory Diseases
- Concluding Remarks
- Conflict of Interest
- References
- Pathogenesis of Non-alcoholic Steatohepatitis and Its Potential Therapeutic StrategiesYoshihiro Ogawa, Takayoshi Suganami, Michiko Itoh, and Miyako Tanaka.
- Introduction
- Interaction Between Adipocytes and Macrophages in Obese Adipose Tissue
- Development of a Novel Rodent Model of NASH
- Identification of Hepatic Crown-Like Structure (hCLS)
- Macrophage-Induced C-Type Lectin (Mincle)
- Role of Mincle in Adipose Tissue Remodeling and Ectopic Fat Accumulation
- Summary
- Acknowledgments
- References
- Multifaceted Translational Approach to Major Mental IllnessAkira Sawa.
- Introduction
- Major Mental Illness Caused by a Combination of Multiple Genetic Risk Factors and Environmental Stressors in the Pathological Trajectory
- Research Infrastructure That Allows a Multifaceted Translational Approach to Major Mental Illness
- Two Representative Studies that Use the Research Infrastructure
- Acknowledgments
- References
- Translational Research of Leptin in Lipodystrophy and Its Related DiseasesKen Ebihara and Kazuwa Nakao, Professor.
- Introduction
- Transgenic Mice Overexpressing Leptin
- Crossbreeding Experiment of LepTg Mice with A-ZIPTg Mice
- Leptin Replacement Therapy in Japanese Patients with Lipodystrophy
- Significance of Hepatic AMPK in the Metabolic Action of Leptin
- fMRI Analysis of Food-Related Brain Activity in Patients with Lipodystrophy
- Conclusions
- References
- Translational Research of the Activation of the C-Type Natriuretic Peptide (CNP)-Guanylyl Cyclase-B Pathway for Skeletal DysplasiaAkihiro Yasoda and Kazuwa Nakao, Professor.
- Introduction
- Skeletal Phenotypes of the CNP/GC-B System in Genetically Engineered Mice
- Importance of CNP/GC-B Signaling in Endochondral Bone Growth in Humans: Lessons from Rare Congenital Skeletal Disorders
- Translational Research into Activation of CNP/GC-B Signaling for Skeletal Dysplasias
- Conclusions and Future Prospects
- Acknowledgments
- References
- Clarity and Challenges in Tissue FibrosisScott L. Friedman.
- TRP Channels: Their Function and Potentiality as Drug TargetsMotohiro Nishida, Koichiro Kuwahara, Daisuke Kozai, Reiko Sakaguchi, and Yasuo Mori.
- Autophagic Cell Death and Cancer ChemotherapeuticsShigeomi Shimizu.
- Adrenomedullin as a Potential Therapeutic Agent for Refractory Ulcerative ColitisKazuo Kitamura, Shinya Ashizuka, Haruhiko Inatsu, and Toshihiro Kita.
- RNA ActivationX. Y. Zhao, J. Voutila, Nagy A. Habib, and Vikash Reebye.
- IL-6: A New Era for the Treatment of Autoimmune Inflammatory Diseases
- III. New Technology for Innovative Medicine
- Proceedings of the Uehara Memorial Foundation. Innovative Medicine: Basic Research and Development. Cardiac Reprogramming for Heart RepairMasaki Ieda.
- Introduction
- Cell Fate Conversion by Transcription Factors
- Direct Reprogramming of Mouse Fibroblasts into Cardiomyocytes in Vitro
- Cardiac Reprogramming in Vivo by Gene Transfer of Defined Factors
- Gata4/Mef2c/Tbx5/Myocd/Mesp1 Reprogram Human Fibroblasts into Cardiomyocyte-Like Cells
- MiR-133 Promotes Cardiac Reprogramming by Repressing Snai1 and Silencing the Fibroblast Profile
- Perspectives and Challenges of Cardiac Reprogramming for Clinical Applications
- Conclusions
- Acknowledgments
- References
- Development of a New In Vivo Optical Probe for Biological Diagnosis and TherapyMichitaka Ozaki, Takeaki Ozawa, and Yuma Yamada.
- Introduction of Mesenchymal Stem Cells for Liver Surgery (Hepatectomy and Transplantation)Shinji Uemoto, Professor, Yasuhiro Fujimoto, Takumi Teratani, Hiroyuki Kanazawa, Junji Iwasaki, Zhao Xiangdong, Yuki Masano, Shintaro Yagi, Koichiro Hata, and Eiji Kobayashi.
- Clinical Liver Transplantation: Deceased Donor vs. Living Donor
- Mesenchymal Stem Cells
- Mesenchymal Stem Cells for Rat Hepatectomy
- Mesenchymal Stem Cells for Pig Ischemia/Reperfusion Injury
- Mesenchymal Stem Cells for Rat Whole Liver Transplantation with a Long Preservation Period
- Experimental Models for Clinical Application
- Future Perspectives
- Conclusion
- References
- Synaptic and Axonal Plasticity Induction in the Human Cerebral CortexYoshikazu Ugawa.
- TIM-3 Is a Novel Therapeutic Target for Eradicating Acute Myelogenous Leukemia Stem CellsKoichi Akashi.
- Introduction
- Search for Surface Antigens Specific to AML LSCs
- TIM-3 Expression and Functions in Normal Hematopoiesis
- TIM-3 Is a Marker of Malignant Stem Cells in Human AML
- Targeting AML-LSCs by Monoclonal Anti-TIM-3 Killing Antibodies in a Xenograft Model
- TIM-3 Is a Functional Molecule for AML LSC Maintenance
- Conclusion
- References
- TGF-β LAP Degradation Products, a Novel Biomarker and Promising Therapeutic Target for Liver FibrogenesisMitsuko Hara, Tomokazu Matsuura, and Soichi Kojima.
- Cell-Based Regenerative Therapy for Liver DiseaseKenichi Horisawa and Atsushi Suzuki.
- Proceedings of the Uehara Memorial Foundation. Innovative Medicine: Basic Research and Development. Cardiac Reprogramming for Heart Repair
- NLM CatalogRelated NLM Catalog Entries
- Innovative MedicineInnovative Medicine
Your browsing activity is empty.
Activity recording is turned off.
See more...